High mRNA expression of PDZK1IP1 negatively prognosticates patient survival in multiple cancers including low-grade gliomas, glioblastomas, pancreatic adenocarcinoma, but not CRC using data from TCGA (Fig. S12a–e). Here, PDZK1IP1 is linked to glioblastoma.